C358A missense polymorphism of the endocannabinoid degrading enzyme fatty acid amide hydrolase (FAAH) and insulin resistance in patients with diabetes mellitus type 2
Abstract
Background
The polymorphism 385 C/A of FAAH has been associated with overweight and obesity. The aim of our study was to investigate the relationship of polymorphism (cDNA 385 C
→
A) of FAAH gene on obesity parameters in patients with diabetes mellitus type 2.
Design
A population of 70 patients with diabetes mellitus type 2 was analyzed. An anthropometric and biochemical nutritional assessment was performed. The statistical analysis was performed for the combined C358A and A358A as a group and wild type C358C as second group.
Results
Fifty-five patients (78.7%) had genotype C358C (wild type group) and 15 (21.3%) patients C358A (14 patients, 20.6%) or A358A (1 patient, 0.7%) (mutant group). BMI (38.9
±
6.4 vs. 39.2
±
5.7, p
<
0.05), weight (96.8
±
17.6
kg vs. 102.5
±
16.8
kg, p
<
0.05), fat mass (42.1
±
16.1
kg. vs. 46.9
±
11.1
kg, p
<
0.05), waist circumference (115.9
±
12.8
cm vs. 121.3
±
12.8
cm, p
<
0.05), insulin (22.5
±
18.8
mUI/L vs. 33.9
±
17.1
UI/L, p
<
0.05) and TNF-alpha (6.1
±
3.4
pg/mL vs. 8.4
±
3.2
pg/mL, p
<
0.05) were higher in mutant type group than wild type. Adiponectin levels (33.3
±
20.8
ng/mL vs. 22.3
±
10.8
ng/mL, p
<
0.05) were higher in wild type group than mutant type group.
Conclusion
There is an association of the mutant type group A358C and A358A of FAAH with a worse cardiovascular profile (weight, body mass index, waist circumference, insulin,TNF-alpha and adiponectin levels) than wild type group.
Keywords: Diabetes mellitus, FAAH, Insulin resistance, Polymorphism
To access this article, please choose from the options below
PII: S0168-8227(09)00544-0
doi:10.1016/j.diabres.2009.12.019
© 2009 Elsevier Ireland Ltd. All rights reserved.
